Kenneth Rockwood, MD
Potential Financial Conflicts of Interest: Dr. Rockwood has worked with each of the drug companies that make cholinesterase inhibitors. The VISTA (Video-Imaging Synthesis of Treating Alzheimer's Disease) trial (9, 10) was an investigator-initiated, peer-reviewed, double-blind clinical trial, funded in part by the Canadian Institutes of Health Research and Janssen-Ortho Canada. He is also the founder and majority shareholder of DementiaGuide, a Web-based company that provides information on dementia and its treatment. DementiaGuide has a contract with Pfizer Canada to improve patient-centered measurement in a clinical trial.
Rockwood K. The Importance of Measuring Executive Function When Studying the Effects of Cognition-Enhancing Agents. Ann Intern Med. 2008;149:358–359. doi: https://doi.org/10.7326/0003-4819-149-5-200809020-00016
Download citation file:
Published: Ann Intern Med. 2008;149(5):358-359.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use